爱尔眼科(300015) - 2017 Q3 - 季度业绩预告

Financial Performance - The net profit attributable to shareholders for the first three quarters of 2017 is expected to be between RMB 608.99 million and RMB 655.83 million, representing a year-on-year growth of 30.00% to 40.00%[3] - For the third quarter of 2017, the net profit attributable to shareholders is projected to be between RMB 246.96 million and RMB 293.80 million, indicating a year-on-year growth of 26.19% to 50.13%[3] - The increase in net profit is primarily attributed to the continuous enhancement of the company's brand influence, expansion of operational scale, and improved operational efficiency[5][6] Non-Recurring Items - The company anticipates a non-recurring loss impact of approximately RMB 30 million on net profit during the reporting period[7] Audit and Disclosure - The financial data in this earnings forecast has not been audited by a registered accountant[4] - The company emphasizes the importance of rational investment and risk awareness for investors, as detailed financial data will be disclosed in the third quarter report[7]